HomeHPX • FRA
Hisamitsu Pharmaceutical Co Inc
€25.80
Nov 22, 10:59:34 PM GMT+1 · EUR · FRA · Disclaimer
StockDE listed securityJP headquartered
Previous close
€25.60
Day range
€25.80 - €25.80
Year range
€21.00 - €28.80
Market cap
364.25B JPY
Avg Volume
6.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
CDP Climate Change Score
D
Market news
Financials
Income Statement
Revenue
Net income
(JPY)Aug 2024Y/Y change
Revenue
39.65B13.66%
Operating expense
18.75B17.95%
Net income
4.31B-1.33%
Net profit margin
10.87-13.18%
Earnings per share
EBITDA
6.35B20.49%
Effective tax rate
28.38%
Total assets
Total liabilities
(JPY)Aug 2024Y/Y change
Cash and short-term investments
122.74B-13.22%
Total assets
350.48B1.79%
Total liabilities
74.55B7.74%
Total equity
275.92B
Shares outstanding
73.34M
Price to book
0.01
Return on assets
3.52%
Return on capital
4.46%
Net change in cash
(JPY)Aug 2024Y/Y change
Net income
4.31B-1.33%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903. Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Founded
1847
Headquarters
Employees
2,759
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu